Fibromyalgia Community Fibromyalgia AWARE Magazine Resources Research About National Fibromyalgia Association Members

 

Skip Interest Selector

Show All 

National Fibromyalgia Association Hails FDA Approval of Cymbaltaź for the

Management of Fibromyalgia as “Important Step” for Patient Care

 

 

ANAHEIM, Calif. (June 17, 2008)---In a statement issued yesterday by National Fibromyalgia Association president and founder Lynne Matallana, the FDA approval of Cymbaltaź for the management of fibromyalgia was hailed as “another important step in the efforts to ensure that people with fibromyalgia will have the availability of effective medications to help reduce the chronic, widespread pain of this life-altering disorder.”

 

Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. The fibromyalgia indication represents the second FDA-approved use for Cymbalta for a pain disorder.

 

Cymbalta is also the second FDA-approved drug for fibromyalgia. Last June, the FDA approved Lyrica (pregabalin), as the first drug to treat fibromyalgia.

 

Matallana, who was diagnosed with fibromyalgia in 1995 before founding the NFA two years later, said, “The FDA approval of the second drug to treat fibromyalgia helps to continue to improve public and medical awareness, and gives the patients hope for additional treatments that will be effective.”

 

Click here to read a consumer update from the U.S. Food and Drug Administration.

  
ABOUT THE NFA:
The National Fibromyalgia Association is a nonprofit 501(c)(3) organization whose mission is to develop and execute programs dedicated to improving the quality of life for people with fibromyalgia by increasing the awareness of the public, media, government and medical communities. The NFA publishes a quarterly magazine, Fibromyalgia AWARE and hosts an award-winning website at http://www.FMaware.org

 


NFA Exhibiting at EULAR 2008

more ...

 

 

 

QUICK FIND LIST

ABOUT NFA

Programs

Our History

Medical Advisory

Board

 

ARTICLES

English

Spanish

 

STORE

Jewelry

Education

Awareness Items

Goodies

Apparel

FIBROMYALGIA

What is Fibromyalgia?

Who is Affected?

What are the Symptoms?

How is Fibromyalgia Diagnosed?

What Causes Fibromyalgia?

Science of Fibromyalgia

How is Fibromyalgia Treated?

What is the Prognosis?

An Overview for the Newly Diagnosed Patient

 

RESEARCH

Abstracts

Clinical Trials

Research Overview

COMMUNITY

Support Group Information

FM Community Events

Leaders Against Pain

Advocacy

Awareness Day

Membership

Member Spotlight

Patient Stories

 

MEDIA

Fact Sheets

Press Releases

RESOURCES

Resource Directory

Glossary of Terms and Definitions

Sponsors

Featured Advertisers

AWARE Magazine

FM Online Newsletter

 

We're On Facebook

 

 

Home | Privacy Policy | General Policy | Change Your Password/Update Your Profile | http://www.fmaware.org/